Risperdal FDA Approval History
FDA Approved: Yes (First approved December 29, 1993)
Brand name: Risperdal
Generic name: risperidone
Company: Johnson & Johnson Innovative Medicine
Treatment for: Schizophrenia, Bipolar Disorder, Autism
Risperdal (risperidone) is an atypical antipsychotic agent indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with Bipolar I Disorder and the treatment of irritability associated with autistic disorder.
Development timeline for Risperdal
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.